Systematic review of methods for evaluating healthcare research economic impact

Health Research Policy and Systems

Volumn 8, Issue , 2010, Pages

  Yazdizadeh, Bahareh ^a   Majdzadeh, Reza ^a   Salmasian, Hojat ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CASE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMIC EVALUATION; FACTUAL DATABASE; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; INVESTMENT; MEDICAL RESEARCH; REVIEW; SYSTEMATIC REVIEW;

EID: 79960147642     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-8-6     Document Type: Review

References (36)

1. Global Ministerial Forum on Research for Health Strengthening Research for Health, Development, and Equity. [cited 2009/07/15], Global Ministerial Forum on Research for Health., http://www.globalforumhealth.org/Media-Publications/Publications/Report-from-Bamako-Strengthening-Research-for-Health-Development-and-Equity
2. World Health Organization The financial crisis and global health, Report of a high-level consultation. 2009, World Health Organization., http://www.who.int/mediacentre/events/meetings/2009_financial_crisis_report_en_.pdf
3. Karnon J. Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysis. Health Policy 2002, 61(3):329-47. 10.1016/S0168-8510(02)00007-6, 12098524.
4. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics 2006, 24(11):1055-1068. 10.2165/00019053-200624110-00003, 17067191.
5. Coyle D, Grunfeld E, Wells G. The assessment of the economic return from controlled clinical trials. A framework applied to clinical trials of colorectal cancer follow-up. European Journal of Health Economics 2003, 4(1):6-11. 10.1007/s10198-002-0142-5, 15609163.
6. Fleurence RL, Torgerson DJ. Setting priorities for research. Health Policy 2004, 69(1):1-10. 10.1016/j.healthpol.2003.11.002, 15484602.
7. Fleurence RL. Setting priorities for research: a practical application of 'payback' and expected value of information. Health Economics 2007, 16(12):1345-57. 10.1002/hec.1225, 17328053.
8. Townsend J, Buxton M, Harper G. Prioritisation of health technology assessment. The PATHS model: methods and case studies. Health Technology Assessment 2003, 7(20):1-82.
9. Murphy K, Topel R. The Economic Value of Medical Research. Paper presented at the December 1999 Conference on the Economic Value of American's Investment in Medical Research. As presented in Exceptional Returns: The Value of America's Investment in Medical Research
10. The Australian Society for Medical Research Exceptional Returns the Value of Investing in Health R&D in Australia. 2003, The Australian Society for Medical Research., http://www.asmr.org.au/Except.pdf
11. The Australian Society for Medical Research Exceptional Returns: The Value of Investing in Health R&D in Australai II. 2008, The Australian Society for Medical Research., http://www.asmr.org.au/ExceptII08.pdf
12. Health Economics Research Group, RAND Europe Medical Research: What's it worth? Estimating the economic benefits from medical research in the UK. 2008, London:UK Evaluation Forum, Health Economics Research Group, RAND Europe.
13. Buxton M, Hanney S. How can payback from health research be assessed?. Health Serv Res Policy 1996, 1:35-43.
14. Hanney S, Davies A, Buxton M. Assessing benefits from health research projects: can we use questionnaires instead of case studies?. Research Evaluation 1999, 8(3):189-199.
15. Stephen RH, Jonathan G, Steven W, Martin JB. Proposed methods for reviewing the outcomes of health research: the impact of funding by the UK's 'Arthritis Research Campaign'. Health Research Policy and System 2004, 2(1):4.
16. Wooding S, Hanney S, Buxton M, Grant J. Payback arising from research funding: evaluation of the Arthritis Research Campaign. Rheumatology 2005, 44(9):1145-56. 10.1093/rheumatology/keh708, 16049052.
17. Nason E, Janta B, Hastings G, Hanney S, O'Driscoll M, Wooding S. Health Research- Making an Impact, The Economic and Social Benefits of HRBFunded Research. 2008, Irland: Health Research Board., http://www.hrb.ie/uploads/tx_hrbpublications/Health_Reseach-Making_an_Impact.pdf
18. Kwan P, Johnston J, Fung AY, Chong DS, Collins RA, Lo SV. A systematic evaluation of payback of publicly funded health and health services research in Hong Kong. BMC Health Serv Resh 2007, 7:121.
19. Primary Health Care Research and Information Service Exploring the impact of primary health care research. 2009, Kalucy L, Jackson-Bowers E, McIntyre E, Hordacre A-L, Reed R, Primary Health Care Research and Information Service., http://www.phcris.org.au
20. Wooding S, Nason E, Klautzer L, Rubin J, Hanney S, Grant J. Policy and practice impacts of research funded by the Economic and Social Research Council: A case study of the Future of Work programme, approach and analysis. RAND Corporation 2007, RAND Coporation., http://www.rand.org/pubs/technical_reports/2007/RAND_TR435.pdf
21. Candian Institute of Health Research Developing a CIHR Framework to Measure the Impact of Health Research. 2005, Candian Institute of Health Research., http://www.cihr-irsc.gc.ca/e/documents/meeting_synthesis_e.pdf
22. Canadian Academy of Health Sciences Making an Impact, A Preferred Framework and Indicators to Measure Returns on Investment in Health Research. 2009, Canadian Academy of Health Sciences., http://www.cahs-acss.ca/e/pdfs/ROI_FullReport.pdf
23. Kuruvilla S, Mays N, Pleasant A, Walt G. Describing the impact of health research: a Research Impact Framework. BMC Health Services Research 2006, 6:134. 10.1186/1472-6963-6-134, 1635046, 17049092.
24. Wells R, Whitworth JA. Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?. Australia & New Zealand Health Policy 2007, 4:14.
25. Siegler M, Weisfeld A, Cronin D. Is medical research cost effective? Response to Murphy and Topel. Perspectives in Biology & Medicine 2003, 46(3 Suppl):S129-37.
26. Silverstein SC. What does economic research tell us about the economic benefits of investments in medical and health research and training?. 2005, http://www.asbmb.org/uploadedFiles/Advocacy/Economic%20Benefits%20of%20Research%20Investments%20(Silverstein,%20SC).pdf
27. Brown ML, Nayfield SG, Shibley LM. Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment. J Natl Cancer Inst 1994, 86(6):424-430. 10.1093/jnci/86.6.424, 8120916.
28. Hanney S, Mugford M, Grant J, Buxton M. Assessing the benefits of health research: lessons from research into the use of antenatal corticosteroids for the prevention of neonatal respiratory distress syndrome. Social Science & Medicine 2005, 60(5):937-47.
29. Kamper Jorgensen F, Arber S, Berkman L, Mackenbach J, Rosenstock L, Teperi J. International Evaluation of Swedish Public Health Research: Part 3. Scandinavian Journal of Public Health 2005, (supp 65):46-84. 10.1080/14034950510033282, 16040452.
30. World Health Organization World Report on Knowledge for Better Health: Strengthening Health Systems. Geneva 2004, World Health Organization., http://www.who.int/rpc/meetings/pub1/en
31. Majdzadeh R, Nejat S, Fotouhi A, Malekafzali H. Iran's Approach to Knowledge Translation. Iranian Journal of Public Health 2009, 38(Supp 1.1):58-60.
32. Croxson B, Hanney S, Buxton M. Routine monitoring of performance: what makes health research and development different?. Journal of Health Services & Research Policy 2001, 6(4):226-232.
33. Peipert JF. The economic value of medical research: is it worth the investment?. Obstetrics & Gynecology 2002, 99(5 Pt 1):835-840.
34. Chattopadhyay SK, Carande-Kulis VG. Economics of prevention: the public health research agenda. J Public Health Manag Pract 2004, 10(5):467-471.
35. Garfinkel MS, Sarewitz D, Porter AL. A societal outcomes map for health research and policy. American Journal of Public Health 2006, 96(3):441-446. 10.2105/AJPH.2005.063495, 1470511, 16449589.
36. Weiss AP. Measuring the impact of medical research: moving from outputs to outcomes. American Journal of Psychiatry 2007, 164(2):206-214. 10.1176/appi.ajp.164.2.206, 17267781.